CD8A and cancer: In contrast to JES6-1A12-containing IL2C, S4B6-containing IL2C has been shown to boost NK cell and memory CD8+ T cell numbers in mice and to enhance their cytolytic capacity against viral infections, malaria78 and cancer cells70,79–81.